Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
|
|
SANGAMO THERAPEUTICS, INC (SGMO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/19/2022 |
3
| Horn Margaret A (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/19/2022 |
3
| Dubois-Stringfellow Nathalie (SVP-Chief Development Officer) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 08/09/2021 |
3
| Willoughby Scott B. (SVP, Gen. Counsel & Secretary) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 03/19/2021 |
3
| Fontenot Jason D. (SVP, Chief Scientific Officer) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 02/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/22/2020 |
3
| BIOGEN INC. (10% Owner) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 02/13/2020 |
3
| Markels John (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 11/26/2019 |
3
| Meyers James R (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 11/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/26/2019 |
3
| Ramelmeier Rolf Andrew (EVP, Technical Operations) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 08/06/2019 |
3
| LOEB GARY (EVP & General Counsel) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 06/18/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/23/2019 |
3
| Woolfson Adrian (EVP, Research and Development) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 10/04/2018 |
3
| Boissel Stephane (EVP, Corporate Strategy) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 06/28/2018 |
3
| Smith Karen L. (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 02/16/2018 |
3
| Turner Heather D (SVP and General Counsel) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 06/29/2017 |
3
| Zakrzewski Joseph S (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 06/29/2017 |
3
| JEFFS ROGER (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 03/02/2017 |
3
| Yi Kathy (Senior VP & CFO) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 12/02/2016 |
3
| Herberts Curt A. III (Senior VP & CBO) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 12/02/2016 |
3
| Conner Edward R. (Senior VP & CMO) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 06/15/2016 |
3
| Carey Robert (Director) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 06/06/2016 |
3
| Macrae Sandy (President and CEO) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 06/25/2012 |
3
| Ramasastry Saira (Director) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 07/11/2011 |
3
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 04/20/2010 |
3
| RINGO WILLIAM R (Director) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 04/02/2010 |
3
| DILLY STEPHEN GEORGE (Director) has filed a Form 3 on SANGAMO BIOSCIENCES INC |
| 11/21/2008 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|